Achilles Therapeutics' GAAP loss for 2021 was $61.099 million, up 84% from $33.199 million the previous year.
Achilles Therapeutics' GAAP loss for 2021 was $61.099 million, up 84% from $33.199 million the previous year.
Achilles Therapeutics reports for 2021
Achilles Therapeutics' GAAP loss for 2021 was $61.099 million, up 84% from $33.199 million the previous year. Source: 
ir.achillestx.com
ir.achillestx.com
English (US) 